Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-052831

SUTRO BIOPHARMA, INC. · STRO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Farah Champsi
10% Owner
Daniel Janney
Director · 10% Owner
Guy P Nohra
10% Owner
Period of report
Oct 1, 2018
Accepted (ET)
Oct 1, 2018 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001382101

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Oct 1, 2018C589,661—A589,661D
Common StockF3,F2Oct 1, 2018C458,331—A1,047,992D
Common StockF4,F2Oct 1, 2018C382,698—A1,430,690D
Common StockF5,F2Oct 1, 2018C514,211—A1,944,901D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Preferred StockF2,F1—Oct 1, 2018C10,201,769D——Common Stock589,6610D
Series C Preferred StockF2,F3—Oct 1, 2018C12,387,324D——Common Stock458,3310D
Series D Preferred StockF2,F4—Oct 1, 2018C9,449,318D——Common Stock382,6980D
Series E Preferred StockF2,F5—Oct 1, 2018C18,698,578D——Common Stock514,2110D

Explanation of responses